The relationship between FUT2 and longevity is indirect and based on mechanistic reasoning rather than robust human evidence. FUT2 (fucosyltransferase 2) determines secretor status: secretors express ABO blood group antigens in bodily fluids, which shapes gut microbiome composition. Some studies suggest non-secretor status (inactive FUT2) is associated with higher risk of inflammatory bowel disease, vitamin B12 deficiency, and certain infections – factors that could theoretically impair healthspan. However, no direct GWAS or longitudinal studies link FUT2 variants to extended lifespan. The evidence remains mechanistic and speculative. MyBody-X tests can report FUT2 genotype, but interpreting it for longevity is not evidence-based. Clinical takeaway: secretor status may influence gut health, but extending life expectancy through FUT2 alone is unproven. Beware of exaggerated anti-aging claims.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-87ea967d01c51321bd5bf295